Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Novartis
Johnson and Johnson
McKinsey
Baxter
AstraZeneca
Farmers Insurance
UBS
Merck
Fuji

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018110

« Back to Dashboard
NDA 018110 describes THALLOUS CHLORIDE TL 201, which is a drug marketed by Lantheus Medcl, Ge Healthcare, Bracco, Mallinkrodt Nuclear, and Trace Life, and is included in six NDAs. It is available from three suppliers. Additional details are available on the THALLOUS CHLORIDE TL 201 profile page.

The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.

Summary for NDA: 018110

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018110

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 018110

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALLOUS CHLORIDE TL 201
thallous chloride tl-201
INJECTABLE;INJECTION 018110 NDA Medi-Physics, Inc. dba GE Healthcare 17156-299 17156-299-16 6.6 mL in 1 VIAL (17156-299-16)
THALLOUS CHLORIDE TL 201
thallous chloride tl-201
INJECTABLE;INJECTION 018110 NDA Medi-Physics, Inc. dba GE Healthcare 17156-299 17156-299-18 8.8 mL in 1 VIAL (17156-299-18)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1mCi/ML
Approval Date:Feb 27, 1996TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
US Army
Cantor Fitzgerald
Citi
Queensland Health
Boehringer Ingelheim
Argus Health
Fish and Richardson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot